Gossamer Bio is preparing to announce the results of its Phase 3 clinical trial focused on treating pulmonary arterial hypertension, a serious and progressive lung disease....
Investors are keenly evaluating two small-cap medical companies, CERo Therapeutics and Xenetic Biosciences, as potential opportunities in the biotechnology sector. Both firms operate in the immunotherapy...
The biotechnology sector is experiencing a significant transformation as it moves towards profitability, with increasing interest from generalist investors. According to a report from Morgan Stanley,...
Scientists have successfully engineered bacteria to produce essential milk proteins, paving the way for dairy-free cheese and yogurt alternatives. This innovative approach eliminates the need for...
